Hudson Canyon Capital Management Amgen Inc Transaction History

Hudson Canyon Capital Management

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Aug 02, 2023	SELL	$212.27 - $248.7 $1.57 Million - $1.83 Million	-7,375 Closed	0 $0
Q2 2021 Aug 02, 2023	BUY	$233.58 - $259.14 $99,505 - $110,393	426 Added 6.13%	7,375 $1.8 Billion
Q1 2021 Aug 02, 2023	SELL	$221.91 - $258.6 $134,477 - $156,711	-606 Reduced 8.02%	6,949 $1.73 Billion
Q4 2020 Aug 02, 2023	BUY	$216.38 - $257.67 $1.63 Million - $1.95 Million	7,555 New	7,555 $1.74 Billion

3,125

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Hudson Canyon Capital Management, based on Form 13F filings with the SEC.

Stay updated on Hudson Canyon Capital Management with notifications on news.